Syndromes and Clinical Management Issues Associated with T-Cell Lymphomas

摘要: T-cell lymphomas have been associated with unique syndromes, and the therapies used to treat characteristic side effects which require special attention by clinician. In this chapter, we will first discuss certain clinical syndromes of origin. addition having worse prognosis than B-cell lymphomas, hemophagocytic syndrome, tumor lysis central nervous system involvement, electrolyte abnormalities, an increased rate skin infections fatigue (in cutaneous lymphoma particularly), second malignancies. part review five FDA-approved agents for lymphomas—denileukin diftitox, bexarotene, vorinostat, romidepsin pralatrexate—and their properties that should be considered treating physicians. Finally, investigational lymphomas.